Details for: SRSF6
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 28.38rCSI 38.66%PRS 14.47
-
CSI 9.66rCSI 9.32%PRS 11.58
-
CSI 9.5rCSI 7.11%PRS 26.23
-
CSI 8.98rCSI 11.77%PRS 23.01
-
CSI 8.39rCSI 10.45%PRS 23.06
-
CSI 7.76rCSI 7.01%PRS 14.57
-
CSI 7.74rCSI 17.14%PRS 15.11
-
CSI 7.51rCSI 33.36%PRS 16
-
CSI 7.48rCSI 11.56%PRS 15.22
-
CSI 6.51rCSI 20.96%PRS 17.16
-
CSI 6.39rCSI 4.75%PRS 24.07
-
CSI 5.78rCSI 6.05%PRS 17.04
-
CSI 5.6rCSI 24.59%PRS 30.22
-
CSI 5.15rCSI 8.79%PRS 32.78
-
CSI 4.84rCSI 19.36%PRS 34.8
-
CSI 4.66rCSI 18.16%PRS 26.68
-
CSI 4.55rCSI 3.7%PRS 17.23
-
CSI 4.54rCSI 8.51%PRS 31.84
-
CSI 4.47rCSI 4.08%PRS 24.68
-
CSI 3.88rCSI 2.7%PRS 19.31
-
CSI 3.8rCSI 9.04%PRS 24.4
-
CSI 3.75rCSI 8.41%PRS 10.05
-
CSI 3.72rCSI 7.41%PRS 27.48
-
CSI 3.62rCSI 8.63%PRS 19.04
-
CSI 3.51rCSI 3.03%PRS 26
-
CSI 3.47rCSI 11.09%PRS 12.29
-
CSI 3.45rCSI 7.6%PRS 18.21
-
CSI 3.23rCSI 7.22%PRS 18.71
-
CSI 3.06rCSI 9.83%PRS 23.56
-
CSI 3.03rCSI 7.2%PRS 20.27
-
CSI 3.03rCSI 7.83%PRS 15.18
-
CSI 2.99rCSI 14.98%PRS 21.45
-
CSI 2.94rCSI 11.02%PRS 13.8
-
CSI 2.89rCSI 3.33%PRS 14.26
-
CSI 2.84rCSI 2.46%PRS 18.3
-
CSI 2.81rCSI 6.86%PRS 16.14
-
CSI 2.69rCSI 8.79%PRS 43.38
-
CSI 2.68rCSI 3.24%PRS 19.35
-
CSI 2.66rCSI 2.46%PRS 29.45
-
CSI 2.64rCSI 5.08%PRS 36.41
-
CSI 2.62rCSI 3.58%PRS 18.47
-
CSI 2.59rCSI 3.34%PRS 10.08
-
CSI 2.57rCSI 2.16%PRS 25.98
-
CSI 2.57rCSI 3.57%PRS 16.72
-
CSI 2.56rCSI 2.67%PRS 16.68
-
CSI 2.54rCSI 5.6%PRS 24.82
-
CSI 2.51rCSI 11.52%PRS 41
-
CSI 2.5rCSI 2%PRS 29.29
-
CSI 2.5rCSI 10.83%PRS 28.7
-
CSI 2.49rCSI 2.06%PRS 16.43
-
CSI 2.44rCSI 2.97%PRS 20.5
-
CSI 2.36rCSI 2.4%PRS 23.28
-
CSI 2.36rCSI 6.3%PRS 13.48
-
CSI 2.3rCSI 3.38%PRS 14.9
-
CSI 2.26rCSI 3.66%PRS 16.54
-
CSI 2.24rCSI 3.5%PRS 38.43
-
CSI 2.22rCSI 3.31%PRS 19.64
-
CSI 2.19rCSI 3.17%PRS 24.25
-
CSI 2.16rCSI 4.48%PRS 16.28
-
CSI 2.1rCSI 2.97%PRS 15.15
-
CSI 2.09rCSI 5.18%PRS 15.07
-
CSI 2.06rCSI 2.14%PRS 19.14
-
CSI 2.04rCSI 2.01%PRS 17.68
-
CSI 2.03rCSI 5.99%PRS 19.68
-
CSI 2.01rCSI 1.76%PRS 21.64
-
CSI 1.97rCSI 2.52%PRS 15.83
-
CSI 1.96rCSI 4.59%PRS 23.93
-
CSI 1.95rCSI 5.59%PRS 23.9
-
CSI 1.95rCSI 1.63%PRS 19.47
-
CSI 1.92rCSI 2.62%PRS 18.04
-
CSI 1.92rCSI 3.05%PRS 21
-
CSI 1.91rCSI 4.38%PRS 15.76
-
CSI 1.9rCSI 2.9%PRS 16.36
-
CSI 1.86rCSI 1.29%PRS 23.08
-
CSI 1.85rCSI 1.78%PRS 16.84
-
CSI 1.84rCSI 2.55%PRS 23.19
-
CSI 1.83rCSI 2.33%PRS 18.91
-
CSI 1.83rCSI 3.32%PRS 13.41
-
CSI 1.83rCSI 2.26%PRS 14.26
-
CSI 1.8rCSI 3.16%PRS 12.16
-
CSI 1.8rCSI 1.66%PRS 16.71
-
CSI 1.78rCSI 3.68%PRS 24.44
-
CSI 1.78rCSI 1.75%PRS 25.53
-
CSI 1.75rCSI 1.22%PRS 17.24
-
CSI 1.73rCSI 4.58%PRS 19.48
-
CSI 1.73rCSI 3.31%PRS 36.62
-
CSI 1.71rCSI 2.52%PRS 25.54
-
CSI 1.66rCSI 1.47%PRS 16.32
-
CSI 1.64rCSI 1.44%PRS 11.82
-
CSI 1.64rCSI 5.31%PRS 19.82
-
CSI 1.63rCSI 2.05%PRS 20.98
-
CSI 1.63rCSI 1.71%PRS 17.41
-
CSI 1.62rCSI 1.42%PRS 18.53
-
CSI 1.62rCSI 9.15%PRS 7.95
-
CSI 1.6rCSI 4.17%PRS 25.35
-
CSI 1.59rCSI 1.51%PRS 17
-
CSI 1.57rCSI 4.49%PRS 28
-
CSI 1.56rCSI 0.92%PRS 22.51
-
CSI 1.55rCSI 1.7%PRS 18.53
-
CSI 1.55rCSI 1.11%PRS 22.25
-
CSI -1.7rCSI -2.9%PRS 32.4%
-
CSI -1.3rCSI -7.8%PRS 10.0%
-
CSI 0.1rCSI 0.6%PRS 6.7%
-
CSI 0.1rCSI 1.6%PRS 49.6%
-
CSI 0.2rCSI 0.7%PRS 12.5%
-
CSI 0.2rCSI 5.5%PRS 30.0%
-
CSI 0.2rCSI 1.9%PRS 33.7%
-
CSI 0.3rCSI 1.5%PRS 24.9%
-
CSI 0.3rCSI 1.9%PRS 41.4%
-
CSI 0.3rCSI 3.5%PRS 31.1%
-
CSI 0.3rCSI 1.5%PRS 30.4%
-
CSI 0.4rCSI 2.3%PRS 24.4%
-
CSI 0.4rCSI 0.7%PRS 13.9%
-
CSI 0.4rCSI 2.6%PRS 12.7%
-
CSI 0.4rCSI 1.5%PRS 26.6%
-
CSI 0.4rCSI 1.1%PRS 16.5%
-
CSI 0.5rCSI 1.4%PRS 10.2%
-
CSI 0.5rCSI 1.4%PRS 30.9%
-
CSI 0.5rCSI 1.3%PRS 26.4%
-
CSI 0.5rCSI 0.8%PRS 12.5%
-
CSI 0.5rCSI 15.2%PRS 36.4%
-
CSI 0.5rCSI 0.9%PRS 9.6%
-
CSI 0.5rCSI 1.1%PRS 21.8%
-
CSI 0.5rCSI 2.4%PRS 41.5%
-
CSI 0.5rCSI 0.8%PRS 25.9%
-
CSI 0.5rCSI 1.1%PRS 17.3%
-
CSI 0.6rCSI 1.0%PRS 11.7%
-
CSI 0.6rCSI 0.8%PRS 9.2%
-
CSI 0.6rCSI 2.6%PRS 15.6%
-
CSI 0.6rCSI 2.9%PRS 22.1%
-
CSI 0.6rCSI 1.6%PRS 21.1%
-
CSI 0.6rCSI 0.9%PRS 15.1%
-
CSI 0.6rCSI 6.1%PRS 44.6%
-
CSI 0.6rCSI 1.2%PRS 16.7%
-
CSI 0.6rCSI 0.7%PRS 23.9%
-
CSI 0.6rCSI 1.5%PRS 26.0%
-
CSI 0.6rCSI 4.6%PRS 43.1%
-
CSI 0.6rCSI 2.7%PRS 40.5%
-
CSI 0.6rCSI 1.6%PRS 9.4%
-
CSI 0.6rCSI 1.8%PRS 26.9%
-
CSI 0.7rCSI 1.5%PRS 16.8%
-
CSI 0.7rCSI 1.1%PRS 9.7%
-
CSI 0.7rCSI 2.3%PRS 29.0%
-
CSI 0.7rCSI 3.9%PRS 23.8%
-
CSI 0.7rCSI 1.9%PRS 25.2%
-
CSI 0.7rCSI 1.1%PRS 19.3%
-
CSI 0.7rCSI 0.9%PRS 17.8%
-
CSI 0.7rCSI 2.8%PRS 14.6%
-
CSI 0.7rCSI 0.7%PRS 30.2%
-
CSI 0.7rCSI 4.3%PRS 36.1%
-
CSI 0.7rCSI 0.6%PRS 20.2%
-
CSI 0.7rCSI 4.8%PRS 49.3%
-
CSI 0.8rCSI 4.1%PRS 29.7%
-
CSI 0.8rCSI 2.0%PRS 21.2%
-
CSI 0.8rCSI 1.4%PRS 15.1%
-
CSI 0.8rCSI 1.4%PRS 22.0%
-
CSI 0.8rCSI 2.5%PRS 11.0%
-
CSI 0.8rCSI 6.1%PRS 29.6%
-
CSI 0.8rCSI 1.2%PRS 18.4%
-
CSI 0.8rCSI 1.8%PRS 26.8%
-
CSI 0.8rCSI 2.6%PRS 24.4%
-
CSI 0.8rCSI 1.5%PRS 14.5%
-
CSI 0.9rCSI 3.0%PRS 26.5%
-
CSI 0.9rCSI 1.3%PRS 17.2%
-
CSI 0.9rCSI 1.2%PRS 22.6%
-
CSI 0.9rCSI 1.7%PRS 40.5%
-
CSI 0.9rCSI 2.3%PRS 41.9%
-
CSI 0.9rCSI 2.6%PRS 18.5%
-
CSI 0.9rCSI 1.5%PRS 25.5%
-
CSI 0.9rCSI 1.1%PRS 8.9%
-
CSI 0.9rCSI 1.3%PRS 26.0%
-
CSI 0.9rCSI 1.1%PRS 11.9%
-
CSI 0.9rCSI 3.9%PRS 31.8%
-
CSI 0.9rCSI 1.1%PRS 16.0%
-
CSI 0.9rCSI 1.4%PRS 16.3%
-
CSI 0.9rCSI 10.3%PRS 29.2%
-
CSI 1.0rCSI 1.6%PRS 19.1%
-
CSI 1.0rCSI 1.2%PRS 25.0%
-
CSI 1.0rCSI 2.1%PRS 26.1%
-
CSI 1.0rCSI 1.1%PRS 33.1%
-
CSI 1.0rCSI 1.5%PRS 18.7%
-
CSI 1.0rCSI 3.8%PRS 22.3%
-
CSI 1.0rCSI 3.2%PRS 19.7%
-
CSI 1.0rCSI 1.2%PRS 19.0%
-
CSI 1.0rCSI 1.3%PRS 18.8%
-
CSI 1.0rCSI 1.8%PRS 9.6%
-
CSI 1.0rCSI 1.7%PRS 10.4%
-
CSI 1.0rCSI 5.6%PRS 39.0%
-
CSI 1.0rCSI 3.9%PRS 9.8%
-
CSI 1.0rCSI 0.8%PRS 16.2%
-
CSI 1.0rCSI 1.4%PRS 16.2%
-
CSI 1.1rCSI 1.3%PRS 9.4%
-
CSI 1.1rCSI 1.6%PRS 24.6%
-
CSI 1.1rCSI 1.7%PRS 14.0%
-
CSI 1.1rCSI 1.1%PRS 28.4%
-
CSI 1.1rCSI 1.6%PRS 28.6%
-
CSI 1.1rCSI 2.0%PRS 20.4%
-
CSI 1.1rCSI 1.6%PRS 12.6%
-
CSI 1.1rCSI 2.9%PRS 31.7%
-
CSI 1.1rCSI 16.3%PRS 39.2%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1581535607
Symbol: SRSF6_HUMAN
Name: Serine/arginine-rich splicing factor 6
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 7556075
Title: Identification and characterization of three members of the human SR family of pre-mRNA splicing factors.
PubMed ID: 7556075
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 11780052
Title: The DNA sequence and comparative analysis of human chromosome 20.
PubMed ID: 11780052
DOI: 10.1038/414865a
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 1577277
Title: SR proteins: a conserved family of pre-mRNA splicing factors.
PubMed ID: 1577277
DOI: 10.1101/gad.6.5.837
PubMed ID: 10757789
Title: Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.
PubMed ID: 10757789
PubMed ID: 12549914
Title: SRp55 is a regulator of calcitonin/CGRP alternative RNA splicing.
PubMed ID: 12549914
DOI: 10.1021/bi026753a
PubMed ID: 15009664
Title: Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors.
PubMed ID: 15009664
PubMed ID: 17081983
Title: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
PubMed ID: 17081983
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 22767602
Title: Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.
PubMed ID: 22767602
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 24440982
Title: Splicing factor SRSF6 promotes hyperplasia of sensitized skin.
PubMed ID: 24440982
DOI: 10.1038/nsmb.2756
PubMed ID: 28112733
Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
PubMed ID: 28112733
DOI: 10.1038/nsmb.3366
PubMed ID: 16959974
Title: The consensus coding sequences of human breast and colorectal cancers.
PubMed ID: 16959974
Sequence Information:
- Length: 344
- Mass: 39587
- Checksum: 72305506CE948B94
- Sequence:
MPRVYIGRLS YNVREKDIQR FFSGYGRLLE VDLKNGYGFV EFEDSRDADD AVYELNGKEL CGERVIVEHA RGPRRDRDGY SYGSRSGGGG YSSRRTSGRD KYGPPVRTEY RLIVENLSSR CSWQDLKDFM RQAGEVTYAD AHKERTNEGV IEFRSYSDMK RALDKLDGTE INGRNIRLIE DKPRTSHRRS YSGSRSRSRS RRRSRSRSRR SSRSRSRSIS KSRSRSRSRS KGRSRSRSKG RKSRSKSKSK PKSDRGSHSH SRSRSKDEYE KSRSRSRSRS PKENGKGDIK SKSRSRSQSR SNSPLPVPPS KARSVSPPPK RATSRSRSRS RSKSRSRSRS SSRD